CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (Q28571835)
Jump to navigation
Jump to search
scientific journal article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain |
scientific journal article |
Statements
1 reference
CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain (English)
1 reference
Zachary Stewart
1 reference
Luz A. Cortes-Burgos
1 reference
Ben S. Zweifel
1 reference
Steven L. Settle
1 reference
Robert A. Pufahl
1 reference
Gary D. Anderson
1 reference
Medora M. Hardy
1 reference
Dana E. Weir
1 reference
George Hu
1 reference
Fernando A. Happa
1 reference
Shanmugam Muthian
1 reference
Matthew J. Graneto
1 reference
Jaime L. Masferrer
1 reference
1 September 2009
1 reference
1 reference
Identifiers
1 reference